Novel Agents and Combinations in Hodgkin Lymphoma
0 ビュー
• 07/09/23
0
0
埋め込む
administrator
加入者
Panelists discuss novel agents, such as HDAC inhibitors, being explored in clinical trials for patients with Hodgkin lymphoma.
For more from this discussion, visit http://www.onclive.com/peer-exchange/lymphoma
もっと見せる
フェイスブックのコメント
SORT BY-
トップコメント
-
最新のコメント